Skip to main content

IDWeek 2022 Main banner

Tweets by IDWeek 2022

Icon Legend

This session is not in your schedule.

This session is in your schedule. Click again to remove it.

Back

Adrian Kilcoyne, MD

Humanigen Inc.

Disclosure(s): Humanigen, Inc: Employee

Poster(s):

1134 - Lenzilumab Treatment in COVID-19 Pneumonia Reduces Circulating Cytokines and Markers of Systemic Inflammation
Friday, October 21, 2022
12:15 PM – 1:30 PM US ET